Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models

por Taoufik, Era, Kouroupi, Georgia, Zygogianni, Ourania, Matsas, Rebecca
Publicado 2018

Patient-Derived Induced Pluripotent Stem Cell-Based Models in Parkinson’s Disease for Drug Identification

por Kouroupi, Georgia, Antoniou, Nasia, Prodromidou, Kanella, Taoufik, Era, Matsas, Rebecca
Publicado 2020

Early Signs of Molecular Defects in iPSC-Derived Neural Stems Cells from Patients with Familial Parkinson’s Disease

por Akrioti, Elissavet, Karamitros, Timokratis, Gkaravelas, Panagiotis, Kouroupi, Georgia, Matsas, Rebecca, Taoufik, Era
Publicado 2022

High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson’s disease

por Antoniou, Nasia, Prodromidou, Kanella, Kouroupi, Georgia, Boumpoureka, Ioanna, Samiotaki, Martina, Panayotou, George, Xilouri, Maria, Kloukina, Ismini, Stefanis, Leonidas, Grailhe, Regis, Taoufik, Era, Matsas, Rebecca
Publicado 2022

Pharmacological intervention in a transgenic mouse model improves Alzheimer’s-associated pathological phenotype: Involvement of proteasome activation

por Djordjevic, Aleksandra N. Mladenovic, Kapetanou, Marianna, Loncarevic-Vasiljkovic, Natasa, Todorovic, Smilja, Athanasopoulou, Sofia, Jovic, Milena, Prvulovic, Milica, Taoufik, Era, Matsas, Rebecca, Kanazir, Selma, Gonos, Efstathios S.
Publicado 2020

Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model

por Cheimonidi, Christina, Grivas, Ioannis N., Sesti, Fabiola, Kavrochorianou, Nadia, Gianniou, Despoina D., Taoufik, Era, Badounas, Fotis, Papassideri, Issidora, Rizzi, Federica, Tsitsilonis, Ourania E., Haralambous, Sylva, Trougakos, Ioannis P.
Publicado 2021